» Articles » PMID: 35456191

First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction

Abstract

Objective: To assess whether there are differences in first-trimester fetal hepatic artery flows depending on pregnancy outcomes.

Methods: The prospective study conducted in 2012-2020 included 1841 fetuses from singleton pregnancies assessed during the routine first-trimester ultrasound examination (between 11- and 14-weeks' gestation). Also, each fetus was examined to determine their hepatic artery flows by measuring the artery's pulsatility index (HA-PI) and peak systolic velocity (HA-PSV).

Results: The fetuses that were classified as belonging to the adverse pregnancy outcome group (those with karyotype abnormalities and congenital heart defects) were characterized by a significantly lower HA-PI and higher HA-PSV compared to normal outcome fetuses.

Conclusion: Hepatic artery flow assessment proved to be a very useful tool in predicting adverse pregnancy outcomes, in particular karyotype abnormalities and congenital heart defects.

References
1.
Maiz N, Valencia C, Emmanuel E, Staboulidou I, Nicolaides K . Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstet Gynecol. 2008; 112(3):598-605. DOI: 10.1097/AOG.0b013e3181834608. View

2.
Rolnik D, Wright D, Poon L, OGorman N, Syngelaki A, de Paco Matallana C . Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377(7):613-622. DOI: 10.1056/NEJMoa1704559. View

3.
Hamada H, Yamada N, Watanabe H, Okuno S, Fujiki Y, Kubo T . Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus. Ultrasound Obstet Gynecol. 2001; 17(5):442-4. DOI: 10.1046/j.1469-0705.2001.00362.x. View

4.
Czuba B, Zarotynski D, Dubiel M, Borowski D, Wegrzyn P, Cnota W . Screening for trisomy 21 based on maternal age, nuchal translucency measurement, first trimester biochemistry and quantitative and qualitative assessment of the flow in the DV - the assessment of efficacy. Ginekol Pol. 2017; 88(9):481-485. DOI: 10.5603/GP.a2017.0088. View

5.
Tan Z, Lai A, Chen C, Chang K, Tan A . Association of trisomy 18 with hepatoblastoma and its implications. Eur J Pediatr. 2013; 173(12):1595-8. DOI: 10.1007/s00431-013-2147-8. View